Cargando…

Hippocampal circuit dysfunction in psychosis

Despite strong evidence of the neurodevelopmental origins of psychosis, current pharmacological treatment is not usually initiated until after a clinical diagnosis is made, and is focussed on antagonising striatal dopamine receptors. These drugs are only partially effective, have serious side effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Knight, Samuel, McCutcheon, Robert, Dwir, Daniella, Grace, Anthony A., O’Daly, Owen, McGuire, Philip, Modinos, Gemma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411597/ https://www.ncbi.nlm.nih.gov/pubmed/36008395 http://dx.doi.org/10.1038/s41398-022-02115-5

Ejemplares similares

Correction: Hippocampal circuit dysfunction in psychosis
por: Knight, Samuel, et al.
Publicado: (2022)

Effects of Benzodiazepine Exposure on Real-World Clinical Outcomes in Individuals at Clinical High-Risk for Psychosis
por: Livingston, Nicholas R., et al.
Publicado: (2023)

M163. GLUTAMATE METABOLITES ARE ASSOCIATED WITH ALTERED HIPPOCAMPAL ACTIVATION BUT NOT HIPPOCAMPAL-STRIATAL CONNECTIVITY IN SUBJECTS WITH A CLINICAL HIGH RISK FOR PSYCHOSIS
por: Hird, Emily, et al.
Publicado: (2020)

Glutamatergic and dopaminergic function and the relationship to outcome in people at clinical high risk of psychosis: a multi-modal PET-magnetic resonance brain imaging study
por: Howes, Oliver D., et al.
Publicado: (2019)

Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosis
por: Modinos, Gemma, et al.
Publicado: (2018)

Corticolimbic dysfunction during facial and prosodic emotional recognition in first-episode psychosis patients and individuals at ultra-high risk
por: Tseng, Huai-Hsuan, et al.
Publicado: (2016)

S150. EMOTIONAL BEHAVIOUR IN HIGH-RISK AND FIRST-EPISODE PSYCHOSIS
por: Falkenberg, Irina, et al.
Publicado: (2020)

Adverse clinical outcomes in people at clinical high-risk for psychosis related to altered interactions between hippocampal activity and glutamatergic function
por: Allen, Paul, et al.
Publicado: (2021)

Correction: Adverse clinical outcomes in people at clinical high-risk for psychosis related to altered interactions between hippocampal activity and glutamatergic function
por: Allen, Paul, et al.
Publicado: (2021)

Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomes
por: Modinos, Gemma, et al.
Publicado: (2021)

Pattern classification of brain activation during emotional processing in subclinical depression: psychosis proneness as potential confounding factor
por: Modinos, Gemma, et al.
Publicado: (2013)

Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosis
por: Davies, Cathy, et al.
Publicado: (2019)

Relationship between Glutamate Dysfunction and Symptoms and Cognitive Function in Psychosis
por: Merritt, Kate, et al.
Publicado: (2013)

M149. THE TOPOGRAPHY OF STRIATAL DOPAMINE AND SYMPTOMS IN PSYCHOSIS: AN INTEGRATIVE PET AND MRI STUDY
por: McCutcheon, Rob, et al.
Publicado: (2020)

Correction: Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment
por: McCutcheon, Robert A., et al.
Publicado: (2023)

Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment
por: McCutcheon, Robert A., et al.
Publicado: (2023)

Examining the variability of neurocognitive functioning in individuals at clinical high risk for psychosis: a meta-analysis
por: Catalan, Ana, et al.
Publicado: (2022)

Altered activation and connectivity in a hippocampal–basal ganglia–midbrain circuit during salience processing in subjects at ultra high risk for psychosis
por: Winton-Brown, T, et al.
Publicado: (2017)

Correction: Altered activation and connectivity in a hippocampal–basal ganglia–midbrain circuit during salience processing in subjects at ultra high risk for psychosis
por: Winton-Brown, T., et al.
Publicado: (2018)

The Topography of Striatal Dopamine and Symptoms in Psychosis: An Integrative Positron Emission Tomography and Magnetic Resonance Imaging Study
por: McCutcheon, Robert A., et al.
Publicado: (2020)

Cortical GABA in Subjects at Ultra-High Risk of Psychosis: Relationship to Negative Prodromal Symptoms
por: Modinos, Gemma, et al.
Publicado: (2017)

The relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging study
por: Jauhar, Sameer, et al.
Publicado: (2018)

The relationship between striatal dopamine and anterior cingulate glutamate in first episode psychosis changes with antipsychotic treatment
por: Jauhar, Sameer, et al.
Publicado: (2023)

Neural correlates of emotional processing in psychosis risk and onset – A systematic review and meta-analysis of fMRI studies
por: Lukow, P.B., et al.
Publicado: (2021)

T150. REAL-TIME FMRI NEUROFEEDBACK TO DOWN-REGULATE SUPERIOR TEMPORAL GYRUS ACTIVITY IN PATIENTS WITH SCHIZOPHRENIA AND AUDITORY HALLUCINATIONS: A PROOF-OF-CONCEPT STUDY
por: Orlov, Natasza, et al.
Publicado: (2018)

Variability of glucose, insulin, and lipid disturbances in first-episode psychosis: a meta-analysis
por: Pillinger, Toby, et al.
Publicado: (2023)

Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models
por: Pillinger, Toby, et al.
Publicado: (2018)

Verbal learning and hippocampal dysfunction in schizophrenia: A meta-analysis
por: Antoniades, Mathilde, et al.
Publicado: (2018)

Correction to: Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models
por: Pillinger, Toby, et al.
Publicado: (2018)

Multi-echo fMRI, resting-state connectivity, and high psychometric schizotypy
por: Waltmann, Maria, et al.
Publicado: (2018)

How can neuroimaging facilitate the diagnosis and stratification of patients with psychosis?
por: Kempton, Matthew J., et al.
Publicado: (2015)

Cellular and molecular signatures of in vivo imaging measures of GABAergic neurotransmission in the human brain
por: Lukow, Paulina Barbara, et al.
Publicado: (2022)

Cannabidiol (CBD) as a novel treatment in the early phases of psychosis
por: Chesney, Edward, et al.
Publicado: (2021)

Speech Illusions in People at Clinical High Risk for Psychosis Linked to Clinical Outcome
por: Hird, Emily J, et al.
Publicado: (2022)

S172. GLUTAMATE RELATED CONNECTIVITY DISTURBANCES OF THE SALIENCE AND DEFAULT MODE NETWORKS IN PSYCHOSIS
por: McCutcheon, Rob, et al.
Publicado: (2020)

Space and astronomy: the people behind the science
por: McCutcheon, Scott, et al.
Publicado: (2005)

Acceptability of cannabidiol in patients with psychosis
por: Chesney, Edward, et al.
Publicado: (2022)

F18. IS SCHIZOPHRENIA A MULTI-SYSTEM DISORDER? CONSIDERING NEUROLOGICAL, IMMUNE, CARDIOMETABOLIC, AND ENDOCRINE ALTERATIONS IN FIRST EPISODE PSYCHOSIS
por: Pillinger, Toby, et al.
Publicado: (2018)

Neural Responsivity to Food Cues in Patients With Unmedicated First-Episode Psychosis
por: Borgan, Faith, et al.
Publicado: (2019)

Integrated metastate functional connectivity networks predict change in symptom severity in clinical high risk for psychosis
por: Gifford, George, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tb7j9cd0j13i89pnbh8tbpk7pd